International Immunology, Vol. 13, No. 11, 1423-1432,
November 2001
© 2001 Japanese Society for Immunology
Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-
and tumor necrosis factor-
in human thyroid carcinoma cells
Immunology Research Unit, Carmel Medical Center, 7 Michal Street, Haifa 34362, and the Faculty of Medicine, Technion, Haifa, Israel
Correspondence to: M. A. Rahat
Expression of MHC class II molecules is restricted to professional antigen-presenting immune cells, but it can be induced by IFN-
in other cell types. Thyroid cells have been shown to induce class II expression (mainly HLA-DR) following stimulation with IFN- and addition of tumor necrosis factor (TNF)-
synergistically enhanced this expression. Class II transactivator (CIITA) has been implicated as the master regulator of MHC class II molecules and its transcription has been shown to be regulated from four different promoters, one of which is responsible for its induction by IFN-. The aim of this study was to find whether CIITA is synergistically induced by IFN- and TNF- in the human thyroid MRO-87-1 cell line, and to investigate the molecular mechanisms responsible for this synergism. We have demonstrated that IFN- and TNF- synergistically induce HLA-DR and CIITA mRNAs, but prolonged incubation resulted in the inhibition of CIITA mRNA accumulation. Several potential mechanisms that could explain the synergistic effect were explored. NF-
B did not bind the CIITA inducible promoter and addition of SN50, which inhibits NF-B translocation to the nucleus, did not change the synergistic effect. Furthermore, IFN- did not induce IB degradation. Synergistic activation of signal transducer and activator of transcription (STAT)-1 or IFN regulating factor (IRF)-1 was not observed, and STAT-1 did not bind the CIITA inducible promoter. IRF-1, although not synergistically induced or activated, bound synergistically to its specific cis element on the CIITA type IV promoter. Thus we propose that IRF-1 binding mediates the synergistic induction of HLA-DR and CIITA in thyroid cells.
Keywords: class II transactivator, HLA-DR, IFN-, IFN regulating factor-1, NF-B, thyroid, tumor necrosis factor-, signal transducer and activator of transcription-1, USF-1
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Baron and J.-L. Davignon Inhibition of IFN-{gamma}-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2 J. Immunol., October 15, 2008; 181(8): 5530 - 5536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Stahl, E. B. Cook, F. M. Graziano, and N. P. Barney Differential and Cooperative Effects of TNF{alpha}, IL-1{beta}, and IFN{gamma} on Human Conjunctival Epithelial Cell Receptor Expression and Chemokine Release Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2010 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pflugheber, B. Fredericksen, R. Sumpter Jr., C. Wang, F. Ware, D. L. Sodora, and M. Gale Jr. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication PNAS, March 19, 2002; (2002) 62055699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pflugheber, B. Fredericksen, R. Sumpter Jr., C. Wang, F. Ware, D. L. Sodora, and M. Gale Jr. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication PNAS, April 2, 2002; 99(7): 4650 - 4655. [Abstract] [Full Text] [PDF]
|
|